The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query TECX owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/TECX"
Use Arkolith to show who owns TECX, which funds added or reduced it, and which SEC filings prove each claim.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | $87.1M | 2.8M | ▲+0.3% Added · +9K sh | Q1 2026 | |
| 2 | TCG Crossover Management, LLC | $37.2M | 1.2M | ▲New +1.2M sh | Q1 2026 | |
| 3 | Aberdeen Group plc | $35.3M | 1.1M | —Held | Q1 2026 | |
| 4 | BlackRock, Inc. | $26.6M | 860K | ▲+0.7% Added · +6K sh | Q1 2026 | |
| 5 | BRAIDWELL LP | $26.2M | 847K | ▼−8.7% Reduced · −80K sh | Q1 2026 | |
| 6 | BAKER BROS. ADVISORS LP | $18.8M | 608K | ▼−33% Reduced · −296K sh | Q1 2026 | |
| 7 | 5AM Venture Management, LLC | $18.8M | 607K | —Held | Q1 2026 | |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | $14.6M | 474K | ▲New +474K sh | Q1 2026 | |
| 9 | VANGUARD GROUP INC | $12.5M | 600K | ▲+5.3% Added · +30K sh | Q4 2025 | |
| 10 | Vestal Point Capital, LP | $10.1M | 328K | —Held | Q1 2026 | |
| 11 | KENNEDY CAPITAL MANAGEMENT LLC | $8.9M | 287K | ▲+37% Added · +77K sh | Q1 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $8.3M | 268K | ▲+1.8% Added · +5K sh | Q1 2026 | |
| 13 | MARSHALL WACE, LLP | $7.1M | 230K | ▲+643% Added · +199K sh | Q1 2026 | |
| 14 | ORBIMED ADVISORS LLC | $7.0M | 227K | ▼−61% Reduced · −348K sh | Q1 2026 | |
| 15 | STATE STREET CORP | $6.6M | 214K | ▲+2.1% Added · +4K sh | Q1 2026 | |
| 16 | Squarepoint Ops LLC | $5.1M | 164K | ▼−18% Reduced · −35K sh | Q1 2026 | |
| 17 | AMERIPRISE FINANCIAL INC | $4.4M | 143K | ▲New +143K sh | Q1 2026 | |
| 18 | Soleus Capital Management, L.P. | $3.8M | 122K | ▲New +122K sh | Q1 2026 | |
| 19 | D. E. Shaw & Co., Inc. | $3.6M | 116K | ▼−3.4% Reduced · −4K sh | Q1 2026 | |
| 20 | WELLS FARGO & COMPANY/MN | $3.5M | 113K | ▼−6.4% Reduced · −8K sh | Q1 2026 | |
| 21 | Woodline Partners LP | $3.1M | 100K | ▼−50% Reduced · −100K sh | Q1 2026 | |
| 22 | NORTHERN TRUST CORP | $2.4M | 78K | ▲+8.4% Added · +6K sh | Q1 2026 | |
| 23 | Point72 Asset Management, L.P. | $2.1M | 69K | ▼−86% Reduced · −424K sh | Q1 2026 | |
| 24 | VANGUARD FIDUCIARY TRUST CO | $2.1M | 68K | ▲New +68K sh | Q1 2026 | |
| 25 | Connor, Clark & Lunn Investment Management Ltd. | $2.1M | 67K | ▼−6.5% Reduced · −5K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 9, 2026 | Vitorovic Stefan | Director | Grant (A) | 10K | $0 |
| Jun 9, 2026 | SPRINGER TIMOTHY A | Director, 10% Owner | Grant (A) | 10K | $0 |
| Jun 9, 2026 | Tipirneni Praveen P. | Director | Grant (A) | 10K | $0 |
| Jun 9, 2026 | Donenberg Phillip B. | Director | Grant (A) | 10K | $0 |
| Jun 8, 2026 | Chutter Jessica Caroline | Director | Grant (A) | 20K | $0 |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise (M) | 3K | $6K |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise (M) | 215 | $3K |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Sell (S) | 6K | $181K |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Sell (S) | 215 | $8K |
| Mar 6, 2026 | Ruddy Marcella K. | Chief Medical Officer | Sell (S) | 10K | $300K |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise (M) | 3K | — |
| Mar 6, 2026 | McNamara Peter | Chief Scientific Officer | Option exercise (M) | 215 | $0 |
| Company | Co-held by | Combined value |
|---|---|---|
| BOSTON SCIENTIFIC CORPBSX | 29 funds | $1.1B |
| NEUROCRINE BIOSCIENCES INCNBIX | 29 funds | $333.5M |
| ELI LILLY & COLLY | 27 funds | $2.9B |
| UNITED THERAPEUTICS CORPUTHR | 27 funds | $392.4M |
| MICROSOFT CORPMSFT | 26 funds | $10.5B |
| AMAZON.COM INCAMZN | 26 funds | $8.4B |
| BROADCOM INCAVGO | 26 funds | $6.2B |
| VISA INC-CLASS A SHARESV | 26 funds | $2.2B |
| COSTCO WHOLESALE CORPCOST | 26 funds | $2.0B |
| ADVANCED MICRO DEVICESAMD | 26 funds | $1.6B |
| REVOLUTION MEDICINES INCRVMD | 26 funds | $1.5B |
| UNITEDHEALTH GROUP INCUNH | 26 funds | $1.4B |
Ranked by how many of TECX's institutional holders also hold each name, a cross-fund conviction signal. Via the MCP server (ticker.co_held).
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for TECX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.